| Literature DB >> 34557851 |
Amy Ronaldson1, Jorge Arias de la Torre1,2,3, Matthew Prina4, David Armstrong5, Jayati Das-Munshi1,6,7, Stephani Hatch1,6, Rob Stewart1,7, Matthew Hotopf1,7, Alexandru Dregan1.
Abstract
BACKGROUND: We aimed to identify specific patterns of physical multimorbidity, defined as the presence of two or more physical long-term conditions, and to examine the extent to which these specific patterns could predict future incident and persistent common mental health disorders (CMDs) in middle-aged adults enrolled in the UK Biobank.Entities:
Keywords: Anxiety; Depression; Exploratory factor analysis; Multimorbidity
Year: 2021 PMID: 34557851 PMCID: PMC8447568 DOI: 10.1016/j.lanepe.2021.100149
Source DB: PubMed Journal: Lancet Reg Health Eur ISSN: 2666-7762
Sample characteristics by physical multimorbidity status
| Overall (n=154,367) | No multimorbidity (n=110,529, 71.6%) | Two LTCs (n=26,750, 17.3%) | Three LTCs (n=10,996, 7.1%) | Four LTCS (n=4003, 2.6%) | Five or more LTCs (n=2089, 1.4%) | |
|---|---|---|---|---|---|---|
| Age | 57 (50-62) | 55 (49-61) | 59 (53-63) | 61 (55-64) | 61 (56-65) | 61 (56-65) |
| Female | 87,210 (56.5) | 62,471 (56.5) | 15,039 (56.2) | 6201 (56.4) | 2279 (56.9) | 1220 (58.4) |
| Deprivation | -1.71±2.83 | -1.74±2.82 | -1.73±2.80 | -1.61±2.88 | -1.43±2.99 | -1.05±3.12 |
| Education level | ||||||
| | 57,300 (37.1) | 40,907 (37.0) | 10,014 (37.4) | 4095 (37.2) | 1525 (38.1) | 759 (36.3) |
| | 29,537 (19.1) | 21,472 (19.4) | 4908 (18.3) | 2035 (18.5) | 743 (18.6) | 379 (18.1) |
| | 67,530 (43.8) | 48,150 (43.6) | 11,828 (44.3) | 4866 (44.3) | 1735 (43.3) | 951 (45.5) |
| Employment status | ||||||
| | 45,998 (29.8) | 28,037 (25.4) | 10,149 (37.9) | 4874 (44.3) | 1879 (46.9) | 1059 (50.7) |
| | 98,879 (64.1) | 76,260 (69.0) | 14,970 (55.3) | 5271 (47.9) | 1698 (42.4) | 680 (33.5) |
| | 9490 (6.1) | 6232 (5.6) | 1631 (6.1) | 851 (7.7) | 426 (10.6) | 350 (16.8) |
| Ethnicity | ||||||
| | 149,924 (97.1) | 107,192 (97.0) | 26,057 (97.4) | 10,746 (97.7) | 3900 (97.4) | 2029 (97.1) |
| Ethnic minority group | 4443 (2.9) | 3337 (3.0) | 693 (2.6) | 250 (2.3) | 103 (2.6) | 60 (2.9) |
| BMI | 26.77±4.55 | 26.23±4.17 | 27.66±4.85 | 28.49±5.26 | 29.26±5.55 | 30.45±6.17 |
| Smoking status | ||||||
| | 65,669 (42.5) | 44,667 (40.4) | 12,328 (46.1) | 5424 (49.3) | 2091 (52.2) | 1159 (55.5) |
| | 88,698 (57.5) | 65,862 (59.6) | 14,422 (53.9) | 5572 (50.7) | 1912 (47.8) | 930 (44.5) |
| Alcohol intake | 21.08±16.94 | 20.82±16.70 | 21.65±17.55 | 21.77±17.62 | 21.92±16.69 | 22.31±17.77 |
| Physical activity | ||||||
| | 1732 (1.1) | 928 (0.8) | 360 (1.3) | 232 (2.1) | 103 (2.6) | 109 (5.2) |
| | 27,129 (17.6) | 18,379 (16.6) | 5026 (18.8) | 2258 (20.5) | 935 (23.3) | 531 (25.4) |
| | 64,704 (41.9) | 46,129 (41.7) | 11,392 (42.6) | 4655 (42.3) | 1685 (42.1) | 843 (40.3) |
| | 60,802 (39.4) | 45,093 (40.8) | 9972 (37.3) | 3851 (35.0) | 1280 (32.0) | 606 (29.0) |
| Baseline CRP level (mg/L) | 2.32±3.94 | 2.06±3.52 | 2.70±4.45 | 3.14±4.95 | 3.52±5.24 | 4.39±6.20 |
| Baseline antidepressant use | 8068 (5.2) | 4291 (3.9) | 1765 (6.6) | 1056 (9.6) | 537 (13.4) | 419 (20.1) |
| Baseline depression | ||||||
| | 18,974 (12.3) | 12,169 (11.0) | 3679 (13.7) | 1830 (16.6) | 775 (19.4) | 521 (24.9) |
| | 135,393 (87.7) | 98,360 (89.0) | 23,071 (86.3) | 9166 (83.4) | 3228 (80.6) | 1568 (75.1) |
| PHQ-9 follow-up | 2.76±3.70 | 2.51±3.43 | 3.04±3.88 | 3.63±4.40 | 4.31±4.89 | 5.25±5.34 |
| PHQ-9 depression | ||||||
| | 8888 (5.8) | 5175 (4.7) | 1792 (6.7) | 1050 (9.55) | 498 (12.4) | 373 (17.9) |
| | 145,479 (94.2) | 105,354 (95.3) | 24,958 (93.3) | 9946 (90.4) | 3505 (87.6) | 1716 (82.1) |
| Baseline anxiety | ||||||
| | 19,494 (12.6) | 11,924 (10.8) | 3966 (14.8) | 2057 (18.7) | 910 (22.7) | 637 (30.5) |
| | 134,873 (87.4) | 98,605 (89.2) | 22,784 (85.2) | 8939 (81.3) | 3093 (77.3) | 1452 (69.5) |
| GAD-7 follow-up | 2.12±3.35 | 1.98±3.18 | 2.25±3.48 | 2.57±3.86 | 2.98±4.17 | 3.47±4.64 |
| GAD-7 anxiety | ||||||
| | 6500 (4.2) | 4037 (3.6) | 1238 (4.6) | 694 (6.3) | 314 (7.8) | 217 (10.4) |
| | 147,867 (95.8) | 106,492 (96.4) | 25,512 (95.4) | 10,302 (93.7) | 3689 (92.2) | 1872 (89.6) |
| Follow-up duration | 7.60±0.87 | 7.61±0.88 | 7.59±0.86 | 7.57±0.85 | 7.55±0.84 | 7.55±0.85 |
BMI=body mass index; GAD=Generalised Anxiety Disorder; IQR=interquartile range; LTC=long-term conditions; PHQ=Patient Health Questionnaire
Deprivation was measured using the Townsend Deprivation Index. Positive values indicate high material deprivation, whereas negative values indicate relative affluence
Unemployed includes carers, those in voluntary work, the long-term sick or disabled, and full-time students
Figure 1PHQ-9 and GAD-7 scores at follow-up by baseline physical multimorbidity status. Boxes represent 50% of the data, and the error bars represent the remainder. The horizontal lines indicate median values.
Prospective associations between physical multimorbidity and depression and anxiety at follow-up
| Depression | ||||||
|---|---|---|---|---|---|---|
| Participants with depression at baseline, outcome: sustained depression (n=18,974) | ||||||
| Unadjusted | Age and sex adjusted | Fully adjusted | ||||
| Physical multimorbidity | ||||||
| | Reference | Reference | Reference | |||
| | 1.31 (1.19 to 1.44) | <0.001 | 1.55 (1.40 to 1.70) | <0.001 | 1.26 (1.14 to 1.40) | <0.001 |
| | 1.80 (1.61 to 2.02) | <0.001 | 2.27 (2.02 to 2.56) | <0.001 | 1.64 (1.44 to 1.86) | <0.001 |
| | 2.21 (1.88 to 2.60) | <0.001 | 2.89 (2.45 to 3.42) | <0.001 | 1.81 (1.52 to 2.17) | <0.001 |
| | 3.04 (2.53 to 3.66) | <0.001 | 4.22 (3.48 to 5.10) | <0.001 | 2.21 (1.79 to 2.72) | <0.001 |
Covariates: Age, sex, deprivation, education level, employment status, ethnicity, BMI, smoking status, alcohol intake, physical activity, CRP level, follow-up duration, baseline antidepressant use, baseline anxiety (for depression analysis), baseline depression (for anxiety analysis)
Multimorbidity patterns identified using EFA. Patterns highlighted in bold were included in the main analyses as the number of participants with multimorbidity (n=43,838, 28.4%) who were included in the pattern was greater than 1%
| Pattern | Eigenvalue | Long-term conditions | No. of participants (%) |
|---|---|---|---|
| Pattern 1 | 4.43 | CFS, CKD, epilepsy, Parkinson's disease | 23 (0.05) |
| Pattern 3 | 2.46 | Hepatitis, liver disease | 27 (0.06) |
| Pattern 4 | 2.11 | Dementia, glaucoma, Meniere's disease, migraine | 77 (0.2) |
| Pattern 6 | 1.48 | Asthma, PCOS, PVD | 94 (0.2) |
| Pattern 9 | 1.23 | Heart failure, MS | 0 (0.0) |
| Pattern 11 | 1.12 | Pernicious anaemia, thyroid problems | 107 (0.2) |
| Pattern 12 | 1.05 | Cancer, osteoporosis | 330 (0.7) |
| Pattern 13 | 1.01 | Connective tissue disorders, psoriasis/eczema | 283 (0.6) |
CFS=chronic fatigue syndrome; CKD=chronic kidney disease; COPD=chronic obstructive pulmonary disorder; IBS=irritable bowel syndrome; MS=multiple sclerosis; PCOS=polycystic ovarian syndrome; PVD=peripheral vascular disease; TIA=transient ischaemic attack
Any male participant with multimorbidity which comprised prostate conditions was included in this pattern; any female with multimorbidity which comprised endometriosis was included in this pattern
Note: Although 12,665 participants fell into one or more of the multimorbidity patterns, the total here of 15,444 participants reflects a certain amount of overlap across patterns. In pattern 9, no participants experienced both conditions constituting the factor. This is likely an artefact of using tetrachoric correlations and an arbitrary factor loading of +/-0.4 to determine groups. It is probable that these two conditions are linked via a third condition that is either unmeasured or included in the analysis but is subthreshold.
Prospective associations between physical multimorbidity patterns and depression at follow-up
| Depression | ||||||
|---|---|---|---|---|---|---|
| Participants with depression at baseline (n=18,974) | ||||||
| Unadjusted | Age and sex adjusted | Fully adjusted | ||||
| Physical multimorbidity pattern | ||||||
| | Reference | Reference | Reference | |||
| | 1.40 (1.29 to 1.53) | <0.001 | 1.65 (1.51 to 1.80) | <0.001 | 1.31 (1.19 to 1.44) | <0.001 |
| | 2.40 (2.04 to 2.83) | <0.001 | 3.33 (2.80 to 3.95) | <0.001 | 1.85 (1.53 to 2.24) | <0.001 |
| | 2.38 (1.69 to 3.37) | <0.001 | 3.16 (2.22 to 4.49) | <0.001 | 1.97 (1.35 to 2.88) | <0.001 |
| | 3.13 (1.98 to 4.93) | <0.001 | 1.18 (3.12 to 7.91) | <0.001 | 2.56 (1.54 to 4.27) | <0.001 |
| | 1.19 (0.94 to 1.52) | 0.147 | 1.50 (1.17 to 1.91) | 0.001 | 1.13 (0.87 to 1.46) | 0.349 |
| | 2.41 (2.10 to 2.76) | <0.001 | 3.00 (2.60 to 3.45) | <0.001 | 1.92 (1.65 to 2.24) | <0.001 |
Covariates: Age, sex, deprivation, education level, employment status, ethnicity, BMI, smoking status, alcohol intake, physical activity, CRP level, follow-up duration, baseline antidepressant use, baseline anxiety (for depression analysis), baseline depression (for anxiety analysis)